Corindus Vascular Robotics (CVRS) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Unity Software stock soars 22% on strong Q3 beat, robust guidance
Tweet
Share
E-mailGet Alerts CVRS Hot Sheet
Join SI Premium – FREE
Corindus Vascular Robotics (NYSE: CVRS) reported Q4 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $800 thousand.
2017 Guidance
Corindus continues to expect full year 2017 revenue to be in the range of $13 million to $15 million. Corindus expects the implementation of at least 25 new cardiovascular programs in 2017.
For earnings history and earnings-related data on Corindus Vascular Robotics (CVRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loar Holdings Inc. (LOAR) Reports Q3 EPS of $0.39 ; Offers Guidance
- Holley Inc. (HLLY) Misses Q3 EPS by 1c ; Offers Guidance
- Icahn Enterprises L.P. (INGR) Tops Q3 EPS by 12c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
